48,833
edits
Difference between revisions of "Endocervical adenocarcinoma in situ"
Jump to navigation
Jump to search
Endocervical adenocarcinoma in situ (view source)
Revision as of 02:20, 25 April 2014
, 02:20, 25 April 2014no edit summary
| Line 5: | Line 5: | ||
| Caption = Endocervical adenocarcinoma in situ. [[H&E stain]]. | | Caption = Endocervical adenocarcinoma in situ. [[H&E stain]]. | ||
| Synonyms = | | Synonyms = | ||
| Micro = | | Micro = Nuclear changes (nuclear crowding/pseudostratification, nuclear enlargement (often cigar-shaped nuclei), coarse chromatin, small nucleolus or nucleoli), +/-mitoses, +/-reduced cytoplasmic mucin, preservation of glandular architecture | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = [[Tubal metaplasia of the uterine cervix|tubal metaplasia]], [[Arias-Stella reaction]], [[endometriosis]], lower uterine segment epithelium (esp. [[proliferative phase endometrium]]), [[endocervical adenocarcinoma]], [[metastasis|metastatic]] adenocarcinoma | | LMDDx = [[Tubal metaplasia of the uterine cervix|tubal metaplasia]], [[Arias-Stella reaction]], [[endometriosis]], lower uterine segment epithelium (esp. [[proliferative phase endometrium]]), [[endocervical adenocarcinoma]], [[metastasis|metastatic]] adenocarcinoma | ||
| Line 18: | Line 18: | ||
| Assdx = squamous lesions ([[LSIL]], [[HSIL]]) | | Assdx = squamous lesions ([[LSIL]], [[HSIL]]) | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = +/-[[HPV]] | ||
| Signs = | | Signs = | ||
| Symptoms = | | Symptoms = asymptomatic | ||
| Prevalence = uncommon | | Prevalence = uncommon | ||
| Bloodwork = | | Bloodwork = | ||
| Line 27: | Line 27: | ||
| Prognosis = | | Prognosis = | ||
| Other = | | Other = | ||
| ClinDDx = [[endometrial carcinoma]] | | ClinDDx = [[endocervical adenocarcinoma]] (invasive), [[endometrial carcinoma]], squamous cervical lesions | ||
| Tx = typically [[LEEP]] | | Tx = typically [[LEEP]] | ||
}} | }} | ||